Hospitalized COVID-19 patients with more severe disease had a relatively higher frequency of cMono and fewer intermediate monocytes (CD16+CD14+), ncMono (CD14−CD16+), and DCs (Figures 4A and S5A–S5C). This evidence concerns the gene CD14 and COVID-19.